Skip to main content

FRIENDS WITH DIABETES INTERNATIONAL

EIN: 20-4947124Monsey, NYZIP: 10952
G80 - Diseases, Disorders & Medical Disciplines501(c)(3)

Mission

1. To provide moral support for people suffering from diabetes and their families;2. To arrange moral support groups;3. To arrange publications with articles of how to cope with diabetes in conjunction with Jewish traditions/heritage/lifestyle; and4. To raise public awareness on the importance of diagnosis and treatment of diabetes through local publications and public seminars.

Financials

YearRevenueExpensesAssets
2023$292k$0$23k
2022$236k$0$82k

Compensation

2023

MORDECHAI SAMET
$0
$0
$0
$0
MOSES FRIEDMAN
$0
$0
$0
$0
ISRAEL TURNHEIM
$0
$0
$0
$0

2022

ISRAEL TURNHEIM
$0
$0
$0
$0
MOSES FRIEDMAN
$0
$0
$0
$0
MORDECHAI SAMET
$0
$0
$0
$0

Similar Organizations

$321k revenue
Same sector (G80)Very similar revenue ($321k vs $292k)Same state (New York)Similar size (7 vs 6 executives)
KUMI URI USA

Brooklyn, NY

$327k revenue
Same sector (G80)Similar revenue ($327k vs $292k)Same state (New York)
$266k revenue
Similar sector (G)Very similar revenue ($266k vs $292k)Same state (New York)Similar size (8 vs 6 executives)
$271k revenue
Similar sector (G)Very similar revenue ($271k vs $292k)Same state (New York)Similar size (8 vs 6 executives)
$272k revenue
Similar sector (G)Very similar revenue ($272k vs $292k)Same state (New York)Similar size (4 vs 6 executives)
YBRP INC

New Rochelle, NY

$175k revenue
Same sector (G80)Comparable revenue ($175k vs $292k)Same state (New York)Similar size (5 vs 6 executives)
Similar sector (G)Very similar revenue ($275k vs $292k)Same state (New York)Similar size (5 vs 6 executives)
Project CASK Inc

New York, NY

$207k revenue
Same sector (G80)Comparable revenue ($207k vs $292k)Same state (New York)Similar size (7 vs 6 executives)
$265k revenue
Similar sector (G)Very similar revenue ($265k vs $292k)Same state (New York)
Same sector (G80)Comparable revenue ($194k vs $292k)Same state (New York)
Data from IRS Form 990 filings (2022-2023).